ICCT: AI 评分 55/100 — AI 分析 (4月 2026)

概要：

ICCT是做什么的？

ICCT的投资论点是什么？

ICCT在哪个行业运营？

ICCT有哪些增长机遇？

• Expansion of iCoreVerify and iCoreVerify+ adoption: The market for automated insurance eligibility verification is growing as healthcare providers seek to reduce claim denials and improve revenue cycle management. iCoreConnect can capitalize on this trend by expanding the features of iCoreVerify and targeting larger healthcare organizations. The market size for healthcare revenue cycle management is projected to reach $107.9 billion by 2029.
• Increased adoption of iCoreExchange: With growing concerns about data privacy and security, the demand for HIPAA-compliant email solutions is increasing. iCoreConnect can promote iCoreExchange as a secure alternative to traditional email for healthcare professionals, targeting practices that handle sensitive patient information. The global healthcare cybersecurity market is projected to reach $38.5 billion by 2027.
• Strategic partnerships with EHR vendors: Collaborating with established EHR vendors to integrate iCoreConnect's solutions into their platforms can provide access to a wider customer base and accelerate adoption. This strategy can leverage the existing infrastructure and relationships of EHR vendors to expand iCoreConnect's market reach.
• Development of new SaaS solutions: Expanding the product portfolio with new SaaS solutions that address emerging needs in the healthcare industry can drive revenue growth and attract new customers. Potential areas for expansion include telehealth platforms, remote patient monitoring solutions, and data analytics tools for healthcare providers.
• Geographic expansion: While currently focused on the United States, iCoreConnect can explore opportunities to expand its operations into other countries with similar healthcare regulations and market needs. This expansion can be achieved through partnerships with local distributors or by establishing a direct presence in new markets.

• iCoreConnect Inc. operates in the Healthcare Information Services industry, providing cloud-based SaaS solutions.
• The company's gross margin stands at 72.1%, indicating a strong ability to control the direct costs associated with its services.
• iCoreConnect has a negative P/E ratio of -0.00, reflecting its current lack of profitability.
• The company's profit margin is -314.8%, indicating significant losses relative to its revenue.
• iCoreConnect operates with 67 employees, reflecting its relatively small size compared to larger competitors.

ICCT提供哪些产品和服务？

• Provides HIPAA-compliant electronic prescription software (iCoreRx).
• Offers a solution to check patient prescription drug history (iCorePDMP).
• Provides automated insurance eligibility verification (iCoreVerify and iCoreVerify+).
• Offers a tool to reveal the revenue potential of each patient (iCoreHuddle and iCoreHuddle+).
• Provides a medical coding reference SaaS solution (iCoreCodeGenius).
• Offers a secure email solution for healthcare professionals (iCoreExchange).
• Provides cloud data backup services (iCoreCloud).
• Offers claims processing and management solutions (iCoreClaims).

ICCT如何赚钱？

• SaaS subscriptions: iCoreConnect generates revenue through recurring subscription fees for its various software solutions.
• Per-transaction fees: Some services, such as claims processing and payment processing, may involve per-transaction fees.
• Managed IT services: iCoreIT provides managed IT services to healthcare practices, generating revenue through service contracts.
• Partnerships: Revenue may be generated through strategic partnerships with other healthcare technology vendors.

• Small to medium-sized healthcare practices.
• Dental practices.
• Physicians and specialists.
• Hospitals and clinics.

• HIPAA compliance: iCoreConnect's focus on HIPAA compliance provides a competitive advantage in the healthcare industry, where data security and privacy are critical.
• Integrated suite of solutions: The company offers a range of integrated solutions that address various needs of healthcare providers, creating a stickier customer base.
• Established customer base: iCoreConnect has an existing customer base that provides a foundation for future growth.
• Specialized expertise: The company has specialized expertise in healthcare IT and regulatory compliance.

什么因素可能推动ICCT股价上涨？

• Upcoming: Potential new partnerships with EHR vendors to expand market reach.
• Ongoing: Increasing adoption of electronic health records and telehealth solutions.
• Ongoing: Growing demand for HIPAA-compliant data security solutions in healthcare.

ICCT的主要风险是什么？

• Potential: Intense competition from larger, more established players in the healthcare IT market.
• Potential: Evolving healthcare regulations and compliance requirements.
• Ongoing: Negative profit margin and limited financial resources.
• Ongoing: OTC market listing and associated risks.

ICCT的核心优势是什么？

• HIPAA-compliant solutions.
• Integrated suite of products.
• Established presence in the healthcare IT market.
• Specialized expertise in healthcare regulatory compliance.

ICCT的劣势是什么？

• Negative profit margin.
• Limited financial resources.
• Small market capitalization.
• OTC market listing.

ICCT有哪些机遇？

• Expansion of telehealth and remote patient monitoring.
• Growing demand for data security and privacy solutions.
• Strategic partnerships with EHR vendors.
• Development of new SaaS solutions for healthcare providers.

ICCT面临哪些威胁？

• Intense competition from larger, more established players.
• Evolving healthcare regulations.
• Cybersecurity threats and data breaches.
• Economic downturn and reduced healthcare spending.

ICCT的竞争对手是谁？

• Accenture — Global consulting and technology services company with a broad range of healthcare IT solutions. — (ACNV)
• Cerner — Major provider of electronic health record (EHR) systems and healthcare IT solutions. — (CGHC)
• Evolus — Focuses on medical aesthetic products and procedures. — (EVLO)
• Hlth Corp — Offers a range of healthcare services and products, including telehealth and remote patient monitoring. — (HLTT)
• InfuCare Rx — Specialty pharmaceutical company. — (INFIQ)

Key Metrics

• MoonshotScore: 55/100

Company Profile

• CEO: Adam V. Chambers
• Headquarters: Ocoee, US
• Employees: 67
• Founded: 2023

AI Insight

• OTC Tier: OTC Other
• Disclosure Status: Unknown